Blonder Tongue Laboratories (BDR) Key Ratios
$0.21
As on 26-Aug-2022 09:30EDT
Market cap
$4 Mln
Revenue (TTM)
$16 Mln
P/E Ratio
--
P/B Ratio
1.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 26.73 | -2.40 | -2.16 | -10.49 | -7.32 |
| EBIT | -- | -- | 30.58 | 8.38 | -13.88 |
| Net Profit | 0.00 | -170.97 | -14.99 | -12.71 | -180.70 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-21 | Dec-20 |
| EBIT-Margin
| -14.40 | -9.67 | -11.96 | 3.89 | -43.43 |
| Net Margin
| -2.75 | -2.20 | -21.83 | -- | -- |
| Return on equity
| -60.10 | -40.84 | -144.58 | 3.72 | -173.81 |
| Return on Capital
| -27.31 | -18.96 | -- | 1.09 | -76.81 |
| Return on Assets
| -18.11 | -13.12 | -17.89 | 0.75 | -50.71 |
| Debt to Equity (x)
| -- | -- | 1.09 | 1.06 | 5.92 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
--
|
1.09
|
-76.81
|
-6.21
|
-9.96
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-144.58
Lower than Peers by 152.09
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
-144.58
|
3.72
|
-173.81
|
-10.21
|
-18.37
|
|
Peer Median
|
7.50
|
--
|
--
|
--
|
--
|
ROA
-17.89
Lower than Peers by 21.38
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
-17.89
|
0.75
|
-50.71
|
-4.37
|
-8.70
|
|
Peer Median
|
3.49
|
--
|
--
|
--
|
--
|
EBIT Margin
-11.96
Lower than Peers by 21.02
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
-11.96
|
3.89
|
-43.43
|
-3.66
|
-6.52
|
|
Peer Median
|
9.06
|
--
|
--
|
--
|
--
|
Net Margin
-21.83
Lower than Peers by 27.94
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
-21.83
|
0.53
|
-45.63
|
-2.75
|
-6.17
|
|
Peer Median
|
6.11
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-2.16
Lower than Peers by 8.60
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
-2.16
|
-0.04
|
-0.17
|
-0.09
|
-0.07
|
|
Peer Median
|
6.45
|
--
|
--
|
--
|
--
|
EBIT Growth
30.58
Higher than Peers by 19.30
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
30.58
|
108.62
|
-878.54
|
48.66
|
-541.12
|
|
Peer Median
|
11.28
|
--
|
--
|
--
|
--
|
Net Profit Growth
-14.99
Lower than Peers by 20.25
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
-14.99
|
101.12
|
-907.28
|
44.59
|
-248.70
|
|
Peer Median
|
5.25
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.09
Higher than Peers by 0.12
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
1.09
|
1.06
|
5.92
|
0.48
|
0.82
|
|
Peer Median
|
0.96
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
--
|
0.27
|
2.40
|
0.47
|
0.79
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.99
Lower than Peers by 0.78
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
0.99
|
1.27
|
1.10
|
1.45
|
1.26
|
|
Peer Median
|
1.77
|
--
|
--
|
--
|
--
|
Quick Ratio
0.42
Lower than Peers by 0.89
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
0.42
|
0.47
|
0.37
|
0.44
|
0.51
|
|
Peer Median
|
1.31
|
--
|
--
|
--
|
--
|
Interest Coverage
-4.93
Lower than Peers by 8.08
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
-4.93
|
1.19
|
-20.62
|
--
|
--
|
|
Peer Median
|
3.15
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
15.61
Lower than Peers by 0.90
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
15.61
|
11.20
|
10.63
|
12.62
|
12.23
|
|
Peer Median
|
16.51
|
--
|
--
|
--
|
--
|
Asset Turnover
0.82
Higher than Peers by 0.30
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
0.82
|
1.41
|
1.11
|
1.17
|
1.41
|
|
Peer Median
|
0.52
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
--
|
40.64
|
47.34
|
47.48
|
44.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
--
|
164.56
|
171.50
|
163.09
|
160.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
--
|
78.95
|
86.48
|
64.94
|
30.55
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
--
|
126.25
|
132.36
|
145.63
|
174.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
1.16
Lower than Peers by 6.02
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
1.16
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
8.18
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
8.18
|
2.11
|
-1.21
|
7.76
|
-5.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
4
Lower than Peers by 898
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Blonder Tongue Laboratories (BDR)
|
4
|
--
|
--
|
--
|
--
|
|
Peer Median
|
902
|
--
|
--
|
--
|
--
|